First, semaglutide activates GLP-1 receptors in the brain, particularly in the hypothalamus, which reduces appetite and changes how you experience hunger
Its 100% quackery, 100% useless and 100% dangerous in the wrong hands
Protect syringes from excessive heat and direct sunlight
In a 2-year trial, acute pancreatitis was reported in 8 semaglutide-treated patients (0.27 cases per 100 patient-years) and 10 placebo-treated patients (0.33 cases per 100 patient-years), both on a background of standard of care.1 In trials of patients receiving oral semaglutide, pancreatitis was reported as a serious adverse event in 6 patients (0.1 events per 100 patient-years) receiving semaglutide versus 1 in comparator-treated patients (less than 0.1 events per 100 patient-years)
If specialist advice is not immediately available, consider the following: Initial treatment : IM hydroxocobalamin 1 mg once daily on alternate days until no further improvement
[Accessed on: February 26, 2012]